← 產業報告目錄
Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Material (Hydroxyethyl Cellulose, Hydroxypropyl Cellulose, Polyacrylic Resins, Xanthan Gum, Carboxymethyl Cellulose, Hyaluronic acid, Alginate, Collagen, Hybrid), By Formulation, By Route of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-12頁數 170報告編號 INSIGHTACE-0cbf77cd0b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 7.98 billion, the global Hydrogel-based Drug Delivery System Market is poised to accelerate to USD 13.43 billion by 2031, demonstrating a CAGR of 6.8% during the 2024–2031 forecast window.
At its core, Hydrogel-based Drug Delivery System pertains to swelled with water to provide medications in a controlled and prolonged manner. Stakeholders across the healthcare landscape are mountingly turning to these solutions to meet contemporary demands.
The market's upward path is propelled by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Hydrogel-based Drug Delivery Market Snapshot
Chapter 4. Global Hydrogel-based Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Material Estimates & Trend Analysis
5.1. By Material & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Material:
5.2.1. Hydroxyethyl Cellulose
5.2.2. Hydroxypropyl Cellulose
5.2.3. Polyacrylic Resins
5.2.4. Xanthan Gum
5.2.5. Carboxymethyl Cellulose
5.2.6. Hyaluronic acid
5.2.7. Alginate
5.2.8. Collagen
5.2.9. Hybrid
5.2.10. Others
Chapter 6. Market Segmentation 2: By Formulation Estimates & Trend Analysis
6.1. By Formulation & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Formulation:
6.2.1. Tablets
6.2.2. Gels
6.2.3. Films
6.2.4. Suppositories
6.2.5. Solutions
6.2.6. Dressings
Chapter 7. Market Segmentation 3: By Route of Administration Estimates & Trend Analysis
7.1. By Route of Administration & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Route of Administration:
7.2.1. Oral
7.2.2. Buccal
7.2.3. Rectal
7.2.4. Vaginal
7.2.5. Ocular
7.2.6. Transdermal
7.2.7. Injectable
Chapter 8. Market Segmentation 4: by Distribution Channel Estimates & Trend Analysis
8.1. by Distribution Channel & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Retail Pharmacy Chains
8.2.4. Drug Stores
8.2.5. Online Sales Channel
Chapter 9. Hydrogel-based Drug Delivery Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.1.2. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.1.3. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.1.4. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.1.5. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.2.2. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.2.3. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.2.4. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.2.5. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.3.2. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.3.3. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.3.4. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.3.5. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.4.2. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.4.3. Latin America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.4.4. Latin America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.4.5. Latin America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.5.2. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.5.3. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.5.4. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.5.5. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. AstraZeneca Plc.
10.2.2. Columbia Laboratories Inc.
10.2.3. Mylan
10.2.4. Teva Pharmaceuticals USA Inc.
10.2.5. Blairex Laboratories Inc.
10.2.6. ARx LLC.
10.2.7. Endo International plc
10.2.8. BioDelivery Sciences International Inc.
10.2.9. Indivior PLC
10.2.10. GSK Plc
10.2.11. Pfizer Inc.
10.2.12. Aquestive Therapeutics Inc.
10.2.13. ZIM LABORATORIES LIMITED
10.2.14. IntelGenx Corp.
10.2.15. NEXGEL
10.2.16. Bliss GVS Pharma Ltd.
10.2.17. Teika Pharmaceutical Co. Ltd.
10.2.18. Medherant Limited
10.2.19. Galderma
10.2.20. Johnson & Johnson
10.2.21. Bausch and Lomb
10.2.22. Ferring B.V
10.2.23. Ocular Therapeutix Inc
10.2.24. 3M company
10.2.25. Coloplast A/S
10.2.26. AD Surgical
10.2.27. AdvaCare Pharma®
10.2.28. McKesson
10.2.29. KIKGEL
10.2.30. Scapa Healthcare
10.2.31. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們